Verve Therapeutics, Inc. is a clinical-stage genetic medicines company. The Company is focused on developing a new approach to the care of cardiovascular. The 5 analysts with month price forecasts for Verve Therapeutics stock have an average target of , with a low estimate of 15 and a high estimate of A high-level overview of Verve Therapeutics, Inc. (VERV) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals. View the latest Verve Therapeutics Inc. (VERV) stock price, news, historical charts, analyst ratings and financial information from WSJ. The latest Verve Therapeutics stock prices, stock quotes, news, and VERV history to help you invest and trade smarter.
(NASDAQ: VERV) Verve Therapeutics currently has 84,, outstanding shares. With Verve Therapeutics stock trading at $ per share, the total value of. Stock analysis for Verve Therapeutics Inc (VERV:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company. Discover real-time Verve Therapeutics, Inc. Common Stock (VERV) stock prices, quotes, historical data, news, and Insights for informed trading and. Verve Therapeutics Inc (VERV) stock price, GURU trades, performance, financial stability, valuations, and filing info from GuruFocus. A valuation method that multiplies the price of a company's stock by the total number of outstanding shares. M USD. Avg Volume. The average number of. View the VERV premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Verve Therapeutics Inc. The average price target is $ with a high forecast of $ and a low forecast of $ The average price target represents a % change from the. Verve Therapeutics Inc. analyst ratings, historical stock prices, earnings estimates & actuals. VERV updated stock price target summary. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends. The current price of VERV is USD — it has increased by % in the past 24 hours. Watch Verve Therapeutics, Inc. stock price performance more closely on. Research Verve Therapeutics' (Nasdaq:VERV) stock price, latest news & stock analysis. Find everything from its Valuation, Future Growth, Past Performance.
Based on short-term price targets offered by nine analysts, the average price target for Verve Therapeutics comes to $ The forecasts range from a low of. Sub Nav - Stock Information. Stock Quote & Chart · Historical Price Lookup. Stock Quote. NASDAQ GS: VERV. $ Aug 30, PM EDT. Change. Price vs Fair Value ; 1-Star Price: $ ; 5-Star Price: $ ; Economic Moat: None ; Capital Allocation: —. Verve Therapeutics (VERV) has a Smart Score of 5 based on an analysis of 8 unique data sets, including Analyst Recommendations, Crowd Wisdom, and Hedge Fund. Real time Verve Therapeutics (VERV) stock price quote, stock graph, news & analysis. Why Is Verve Therapeutics, Inc. (VERV) the Most Shorted Stock Loved by Analysts Now? (Insider Monkey) +% +%. Verve Therapeutics Inc. ; Open. $ Previous Close$ ; YTD Change. %. 12 Month Change. % ; Day Range - 52 Wk Range - View Verve Therapeutics, Inc. VERV stock quote prices, financial information, real-time forecasts, and company news from CNN. Verve Therapeutics, Inc. (VERV) ; Jul 19, , , , , ; Jul 18, , , , ,
The last closing price for Verve Therapeutics was $ Over the last year, Verve Therapeutics shares have traded in a share price range of $ to $ Verve Therapeutics Inc VERV:NASDAQ · Open · Day High · Day Low · Prev Close · 52 Week High · 52 Week High Date11/07/23 · 52 Week Low About Verve Therapeutics (VERV). Verve Therapeutics, Inc. is a genetic medicines company, which engages in the development of approach to the care of. Historical daily share price chart and data for Verve Therapeutics since adjusted for splits and dividends. The latest closing stock price for Verve. Track Verve Therapeutics Inc (VERV) Stock Price, Quote, latest community messages, chart, news and other stock related information.
Provided by Alpha Vantage. Select a stock. apple; wise. On average, Wall Street analysts predict that Verve Therapeutics's share price could reach $ by Aug 12, The average Verve Therapeutics stock price. How much percentage Verve Therapeutics Inc is up from its 52 Week low? Verve Therapeutics Inc (VERV) share price is $ It is up by 1% from its 52 Week Low. The forecasts range from a low of $ to a high of $ A stock's price target is the price at which analysts consider it fairly valued with respect to.